In 2014, the expression levels of Enolase-1 (ENO1) and Cyclophilin A (CYPA) in NPC were significantly correlated with the clinical stage via quantitative proteomics and immunohistochemistry [152]. The gene discussed is PPIA; the disease is nasopharyngeal carcinoma.